
At the center of the debate are the growing number of manufacturer demands for claims data as a condition of 340B pricing.
The FDA has issued a final rule amending the final monograph for OTC dandruff, seborrheic dermatitis, and psoriasis drug products to include the combination of 1.8% coal tar solution and 1.5% menthol in a shampoo drug product to control dandruff. This regulation is effective April 5.
To see more Hot off the Press news articles,
To go to the Drug Topics homepage,






